MitoxantroneDexamethasoneGlucocorticoidsAnthraquinonesAntineoplastic Combined Chemotherapy ProtocolsCytarabineAntineoplastic AgentsAnti-Inflammatory AgentsATP-Binding Cassette TransportersPrednisoneDrug Resistance, NeoplasmDoxorubicinDrug Resistance, MultipleReceptors, GlucocorticoidVidarabineEtoposideDaunorubicinAntiemeticsRemission InductionP-GlycoproteinNeoplasm ProteinsIdarubicinDose-Response Relationship, DrugDrug Administration ScheduleTreatment OutcomeAmsacrineCyclophosphamideRazoxaneTopoisomerase InhibitorsMifepristoneDrug EvaluationTaxoidsRNA, MessengerIntercalating AgentsEstramustineVincristineTopotecanCardiotoxinsLeukemia, MyeloidProstatic NeoplasmsMultiple MyelomaVomitingHydrocortisoneLymphoma, Non-HodgkinTumor Cells, CulturedPrednisoloneThalidomideLeukemia, Myeloid, AcuteCells, CulturedSalvage TherapyDNA Topoisomerases, Type II